Compass Therapeutics CMPX
NASDAQ CMPX
$0.90 -0.14 (-13.36%)
At close: Oct 1, 2026 · 4:00 PM EDT

Compass Therapeutics (CMPX) Cash & Equivalents (2018 - 2026)

Updated

Compass Therapeutics (CMPX) posted Cash & Equivalents of $36.02 million for Q2 2026, up 53.8% from $23.42 million a year earlier but down 35.4% from the prior quarter.

Analysis

Compass Therapeutics (CMPX) Cash & Equivalents (2018 - 2026) Analysis & Trends

At the end of FY2025, Compass Therapeutics' Cash & Equivalents came in at $31.21 million, down 29.1% from FY2024.

  • Annual Cash & Equivalents shows a five-year compound annual growth rate of -7.9% (FY2020 to FY2025).
  • In prior years, Compass Therapeutics' Cash & Equivalents was $44.05 million in FY2024 (+81.8%), $24.23 million in FY2023 (-30.7%), $34.95 million in FY2022 (-75.8%) and $144.51 million in FY2021 (+207.0%).
  • Quarterly Cash & Equivalents has run from a low of $16.48 million in Q3 2022 to a high of $144.51 million in Q4 2021 over five years.
  • On a year-over-year basis, Cash & Equivalents increased in six of the last eight quarters, with growth averaging 25.6%.
  • The strongest year-over-year quarter for Cash & Equivalents in the past five years was Q1 2022, with growth of 243.6%; the weakest was Q1 2023, with a decline of 80.2%.
  • According to Business Quant data, Cash & Equivalents for the three prior quarters was $55.74 million (Q1 2026), $31.21 million (Q4 2025) and $46.78 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 20.42 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 6.57 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 6.85 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 7.62 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 4.89 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 13.99 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 3.18 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 976.00 Mn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 6.14 Bn
10 Compass Therapeutics 187.29 Mn 187.29 Mn - 36.02 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 36.02 Mn
Mar 31, 2026 55.74 Mn
Dec 31, 2025 31.21 Mn
Sep 30, 2025 46.78 Mn
Jun 30, 2025 23.42 Mn
Mar 31, 2025 41.62 Mn
Dec 31, 2024 44.05 Mn
Sep 30, 2024 37.37 Mn
Jun 30, 2024 19.40 Mn
Mar 31, 2024 43.48 Mn
Dec 31, 2023 24.23 Mn
Sep 30, 2023 30.43 Mn
Jun 30, 2023 19.28 Mn
Mar 31, 2023 27.03 Mn
Dec 31, 2022 34.95 Mn
Sep 30, 2022 16.48 Mn
Jun 30, 2022 26.24 Mn
Mar 31, 2022 136.40 Mn
Dec 31, 2021 144.51 Mn
Sep 30, 2021 25.51 Mn
API Access

Compass Therapeutics Cash & Equivalents API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=CMPX&period=max&api_key=YOUR_API_KEY